Abstract
The advent of CRISPR-Cas9 gene-editing technology has revolutionized pharmaceutical research, offering unprecedented potential for targeted therapies and the development of novel drugs. By enabling precise modifications in the DNA of living organisms, CRISPR-Cas9 facilitates the study of gene function, the identification of disease-associated genes, and the development of gene-based treatments. This article explores the applications of CRISPR-Cas9 in pharmaceutical research, including drug discovery, genetic disease modeling, and gene therapy. Additionally, it discusses the challenges, ethical considerations, and future directions of CRISPR-based therapeutics in the pharmaceutical industry.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Dr. Muhammad Usman Arshad (Author)